Finance

Beta
Ask
Lists
001367:SHE
Zhejiang Haisen Pharmaceutical Co Ltd
CNÂĄ20.31
+1.30%
(+0.26) 1D
Jun 18, 3:04:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 001367...
Open
CNÂĄ20.19
High
CNÂĄ20.46
Low
CNÂĄ19.80
Mkt. cap
3.17B
Avg. vol.
1.97M
Volume
1.53M
Dividend
0.57%
Quarterly dividend
CNÂĄ0.03
Ex-dividend date
May 13, 2026
P/E ratio
23.10
52-wk high
CNÂĄ28.00
52-wk low
CNÂĄ18.60
EPS
CNÂĄ0.88
Shares outstanding
152.35M
No. of employees
705
Open
CNÂĄ20.19
High
CNÂĄ20.46
Low
CNÂĄ19.80
Mkt. cap
3.17B
Avg. vol.
1.97M
Volume
1.53M
Dividend
0.57%
Quarterly dividend
CNÂĄ0.03
Ex-dividend date
May 13, 2026
P/E ratio
23.10
52-wk high
CNÂĄ28.00
52-wk low
CNÂĄ18.60
EPS
CNÂĄ0.88
Shares outstanding
152.35M
No. of employees
705
News stories
From sources across the web
About Zhejiang Haisen Pharmaceutical Co Ltd
CEO-
Employees705
FoundedFeb 18, 1998
Headquarters-
SectorPharmaceutical industry
Websitehaisenpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
123.61M
116.78M
173.39M
107.19M
Cost of goods sold
69.12M
60.07M
95.96M
55.54M
Cost of revenue
69.12M
60.07M
95.96M
55.54M
Research and development expenses
8.27M
10.46M
10.69M
9.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.00M
15.28M
15.38M
10.13M
Operating expense
22.05M
27.16M
29.22M
19.22M
Total operating expenses
91.16M
87.23M
125.18M
74.75M
Operating income
32.44M
29.55M
48.21M
32.44M
Other non operating income
-851.96K
702.68K
-856.42K
-1.39M
EBT including unusual items
34.31M
31.87M
54.39M
33.15M
EBT excluding unusual items
34.08M
32.12M
51.26M
33.19M
Income tax expense
4.72M
4.46M
6.72M
4.25M
Effective tax rate
13.77%
13.98%
12.36%
12.81%
Other operating expenses
1.30M
1.29M
977.40K
1.01M
Net income
29.58M
27.42M
47.67M
28.91M
Net profit margin
23.93%
23.48%
27.49%
26.97%
Earnings per share
-
-
-
-
Interest and investment income
1.51M
3.01M
4.04M
2.22M
Interest expense
-87.85K
-86.38K
-86.89K
-76.70K
Net interest expenses
1.43M
2.93M
3.95M
2.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.80M
33.31M
53.63M
37.86M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer